Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban thromboprophylaxis registry after total knee or hip replacement in Chinese patients
ChiCTR1800014851Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of apixaban in venous thromboembolism (VTE), sponsored by Peking Union Medical College Hospital. Primary endpoints: Composite of major bleeding and clinically relevant non-major bleeding and Apixaban treatment period definition. Started Sep 2015; status: recruiting.
02
Drugs
apixaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on ChiCTR1800014851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014851.